HeartBeam, Inc. ( BEAT) Stock. Should you Buy or Sell? $ 1.33
0.05 (3.62 %)
HeartBeam, Inc. Analysis
Updated on 10-09-2022| Symbol | BEAT |
| Price | $1.33 |
| Beta | 0.000 |
| Volume Avg. | $96.38 thousand |
| Market Cap | $10.63 M |
| 52 Week Range | $1.12 - $5.47 |
HeartBeam, Inc. opened the day at $1.33 which is +'3.62 % on yesterday's close. HeartBeam, Inc. has a 52 week high of $5.47 and 52 week low of $1.12, which is a difference of $4.35. We like to see positive, upward trending shares, preferably with momentum. Market capitalization is $10.63 M and total net profit is $0 which means the company is trading at inf times profit to market capitalization. Theoretically, if you were to buy HeartBeam, Inc. for $10.63 M, it would take 15 years to get your money back. HeartBeam, Inc. are in the Health Information Services space which will have a sweet spot and industry standard for net profit multiples.
Price Chart
Financials
HeartBeam, Inc. Stock Forecast - Is HeartBeam, Inc. a Buy or Sell?
| DCF Score | Strong Buy | |
| ROE Score | Strong Sell | |
| ROA Score | Strong Sell | |
| DE Score | Neutral | |
| PE Score | Sell | |
| PB Score | Strong Buy | |
| Overall Recommendation | Neutral |
Growth and Value
| PE Ratio | -2.290 |
| Dividend Yiel | 0.000 |
| Net Profit Margin | 0.000 |
Valuing HeartBeam, Inc.
| Price Book Value Ratio | 1.208 | Price To Book Ratio | 1.208 |
| Price To Sales Ratio | 0.000 | Price Earnings Ratio | -2.290 |
How liquid is HeartBeam, Inc.
| Current Ratio | 12.647 |
| Quick Ratio | 12.044 |
Debt
| Debt Ratio | 0.079 | Debt Equity Ratio | 0.086 |
| Long Term Debt To Capitalization | 0.000 | Total Debt To Capitalization | 0.000 |
Latest news about HeartBeam, Inc.
HeartBeam, Inc. (NASDAQ:BEAT ) Q2 2022 Earnings Conference Call August 11, 2022 4:30 PM ET Company Participants Branislav Vajdic - Chief Executive Officer & Founder Jon Hunt - Chief Business Officer Rick Brounstein - Chief Financial Officer Conference Call Participants Bill Sutherland - The Benchmark Company Jason Kolbert - Dawson James Operator Greetings and welcome to the HeartBeam Second Quarter 2022 Financial Results Conference Call. At this time, all participants will be in a listen-only mode.
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Host Second Quarter 2022 Results Conference Call on Thursday August 11, 2022 at 4:30 p.m. Eastern Time
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Present at LD Micro Invitational XII Conference on June 7, 2022
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Participate in the H.C. Wainwright Global Investment Conference May 23-26, 2022
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Host First Quarter 2022 Results Conference Call on Thursday May 12, 2022 at 4:30 p.m. Eastern Time
About HeartBeam, Inc.
Description :
HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.
